UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID.
A novel antibody therapy makes the immune system of old mice appear younger, allowing the animals to better fend off ...
A research team led by the United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, that includes ...
Their preclinical study confirmed that in older mice between 18 and 24 months of age treatment using an antibody that targeted the myeloid-leaning HSCs for destruction had more of the balanced HSCs, ...
Affinity measurement was obtained through a contrived sample and buffer using recombinant SARS-CoV-2 RBD and monoclonal ...
New federal data shows that a first-of-its-kind treatment designed to temporarily protect infants from severe respiratory ...
"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and ...
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models ...
Discover Pfizer's innovative patent for multi-drug Antibody Drug Conjugates and Linking Assembly Units, enabling precise and effective drug delivery. Explore the cutting-edge technology behind ...
The FDA has turned down a pair of marketing applications for Regeneron’s CD20xCD3 bispecific antibody odronextamab to treat ...
Researchers discover that the COVID-19 virus can trigger the production of "abzymes" -- antibodies that act like enzymes -- ...
CCHFV poses a threat to U.S. military personnel and hospital staff as well as residents of a growing number of countries, ...